Health Care Spending and the ACA
Health Care Spending and Chronic Care
Health Care Spending and Prescription Drugs
Letter to CMS: CAHC writes in opposition to the administration’s proposed International Pricing Index for Part B treatments - December 2018
Coalition Letter to HHS opposing International Pricing Index for Part B treatments - November 2018
Letter to FDA Commissioner Scott Gottlieb opposing drug importation workgroup - October 2018
Letter to HHS Secretary Alex Azar: CAHC responds to the Trump administration’s “American Patients First” blueprint for improving prescription drug affordability - July 2018.
Letter to President Trump: Improving prescription drug access and affordability through value-based payment arrangements (VBAs) - April 2018.
Letter to the Senate HELP Committee on Prescription Drug Costs - December 2017
Infographic: Drug Competition Creates Lower Drug Prices- Infographic - March 2016
Letter to Senators Wyden and Grassley: Request for Information on Policy Issues Including the Financial Impact of High Prices of Breakthrough Drugs, Ensuring Patient Access, and Improving Marketplace Transparency - March 2016